However, ZFPM2-AS1 expression did not have a significant correlation with other clinical characteristics, including age, gender, tumor differentiation, smoking history, and lymph node metastasis (Table 1). This evidence concerns the gene ZFPM2 and metastatic malignant neoplasm in the lymph nodes.